These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29420552)

  • 1. Human Borrelia miyamotoi infection in California: Serodiagnosis is complicated by multiple endemic Borrelia species.
    Krause PJ; Carroll M; Fedorova N; Brancato J; Dumouchel C; Akosa F; Narasimhan S; Fikrig E; Lane RS
    PLoS One; 2018; 13(2):e0191725. PubMed ID: 29420552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States.
    Krause PJ; Narasimhan S; Wormser GP; Barbour AG; Platonov AE; Brancato J; Lepore T; Dardick K; Mamula M; Rollend L; Steeves TK; Diuk-Wasser M; Usmani-Brown S; Williamson P; Sarksyan DS; Fikrig E; Fish D;
    Emerg Infect Dis; 2014 Jul; 20(7):1183-90. PubMed ID: 24960072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borrelia burgdorferi and Borrelia miyamotoi seroprevalence in California blood donors.
    Brummitt SI; Kjemtrup AM; Harvey DJ; Petersen JM; Sexton C; Replogle A; Packham AE; Bloch EM; Barbour AG; Krause PJ; Green V; Smith WA
    PLoS One; 2020; 15(12):e0243950. PubMed ID: 33370341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a Borrelia miyamotoi membrane antigen (BmaA) for serodiagnosis of Borrelia miyamotoi disease.
    Harris EK; Brandt KS; Van Gundy TJ; Goodrich I; Wormser GP; Armstrong BA; Gilmore RD
    Ticks Tick Borne Dis; 2020 Sep; 11(5):101476. PubMed ID: 32723629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new
    Cutler S; Vayssier-Taussat M; Estrada-Peña A; Potkonjak A; Mihalca AD; Zeller H
    Euro Surveill; 2019 May; 24(18):. PubMed ID: 31064634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borrelia miyamotoi in vectors and hosts in The Netherlands.
    Wagemakers A; Jahfari S; de Wever B; Spanjaard L; Starink MV; de Vries HJC; Sprong H; Hovius JW
    Ticks Tick Borne Dis; 2017 Mar; 8(3):370-374. PubMed ID: 28065617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a serological test for the diagnosis of Borrelia miyamotoi disease in Europe.
    Jahfari S; Sarksyan DS; Kolyasnikova NM; Hovius JW; Sprong H; Platonov AE
    J Microbiol Methods; 2017 May; 136():11-16. PubMed ID: 28259789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borrelia miyamotoi BipA-like protein, BipM, is a candidate serodiagnostic antigen distinguishing between Lyme disease and relapsing fever Borrelia infections.
    Brandt KS; Armstrong BA; Goodrich I; Gilmore RD
    Ticks Tick Borne Dis; 2024 May; 15(3):102324. PubMed ID: 38367587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of Borrelia miyamotoi infection in a highly endemic area of Lyme disease.
    Marcos LA; Smith K; Reardon K; Weinbaum F; Spitzer ED
    Ann Clin Microbiol Antimicrob; 2020 May; 19(1):22. PubMed ID: 32473652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Protein Array for Detection of Antibodies against the Tick-Borne Pathogen Borrelia miyamotoi.
    Hoornstra D; Stukolova OA; Karan LS; Sarksyan DS; Kolyasnikova NM; Markelov ML; Cherkashina AS; Dolgova AS; Sudina AE; Sokolova MI; Platonov AE; Hovius JW
    Microbiol Spectr; 2022 Dec; 10(6):e0203622. PubMed ID: 36314925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niche partitioning of Borrelia burgdorferi and Borrelia miyamotoi in the same tick vector and mammalian reservoir species.
    Barbour AG; Bunikis J; Travinsky B; Hoen AG; Diuk-Wasser MA; Fish D; Tsao JI
    Am J Trop Med Hyg; 2009 Dec; 81(6):1120-31. PubMed ID: 19996447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Borrelia miyamotoi in febrile patients and ticks in Alsace, an endemic area for Lyme borreliosis in France.
    Boyer PH; Koetsveld J; Zilliox L; Sprong H; Talagrand-Reboul É; Hansmann Y; de Martino SJ; Boulanger N; Hovius JW; Jaulhac B
    Parasit Vectors; 2020 Apr; 13(1):199. PubMed ID: 32303256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.
    Koetsveld J; Platonov AE; Kuleshov K; Wagemakers A; Hoornstra D; Ang W; Szekeres S; van Duijvendijk GLA; Fikrig E; Embers ME; Sprong H; Hovius JW
    Clin Microbiol Infect; 2020 Apr; 26(4):513.e1-513.e6. PubMed ID: 31404672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoproteomic analysis of Borrelia miyamotoi for the identification of serodiagnostic antigens.
    Harris EK; Harton MR; de Mello Marques MA; Belisle JT; Molins CR; Breuner N; Wormser GP; Gilmore RD
    Sci Rep; 2019 Nov; 9(1):16808. PubMed ID: 31727932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroreactivity to the C6 Peptide in Borrelia miyamotoi Infections Occurring in the Northeastern United States.
    Molloy PJ; Weeks KE; Todd B; Wormser GP
    Clin Infect Dis; 2018 Apr; 66(9):1407-1410. PubMed ID: 29149281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borrelia miyamotoi Infection in Immunocompromised Man, California, USA, 2021.
    Rubio LA; Kjemtrup AM; Marx GE; Cronan S; Kilonzo C; Saunders MEM; Choat JL; Dietrich EA; Liebman KA; Park SY
    Emerg Infect Dis; 2023 May; 29(5):1011-1014. PubMed ID: 37081591
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Koetsveld J; Draga ROP; Wagemakers A; Manger A; Oei A; Visser CE; Hovius JW
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and Geographic Distribution of Borrelia miyamotoi, Borrelia burgdorferi, and Babesia microti Infections in New England Residents.
    Johnston D; Kelly JR; Ledizet M; Lavoie N; Smith RP; Parsonnet J; Schwab J; Stratidis J; Espich S; Lee G; Maciejewski KR; Deng Y; Majam V; Zheng H; Bonkoungou SN; Stevens J; Kumar S; Krause PJ
    Clin Infect Dis; 2022 Mar; ():. PubMed ID: 35325084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eco-epidemiological factors contributing to the low risk of human exposure to ixodid tick-borne borreliae in southern California, USA.
    Lane RS; Fedorova N; Kleinjan JE; Maxwell M
    Ticks Tick Borne Dis; 2013 Sep; 4(5):377-85. PubMed ID: 23643357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the tick-borne relapsing fever spirochete Borrelia hermsii by using a species-specific monoclonal antibody.
    Schwan TG; Gage KL; Karstens RH; Schrumpf ME; Hayes SF; Barbour AG
    J Clin Microbiol; 1992 Apr; 30(4):790-5. PubMed ID: 1572965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.